Development of a Photocrosslinkable Collagen–Bone Matrix Hydrogel for Bone Tissue Engineering

Abstract

Bone tissue engineering aims to restore lost bone and create an environment conducive to new bone formation. To address this challenge, we developed a novel biomimetic hydrogel that combines maleic anhydride–modified type I collagen (ColME) with maleic anhydride–modified demineralized and decellularized porcine bone matrix particles (mDBMp), forming a composite ColME–mDBMp (CMB) hydrogel. Chemical modification of collagen resulted in a high degree of substitution, thereby enhancing its photocrosslinkability. Integration of mDBMp into the ColME hydrogel via photocrosslinking resulted in enhanced physiological stability, reduced shrinkage, and improved mechanical strength compared to gelatin methacrylate (GelMA)-based hydrogels. Moreover, mineralization of the CMB hydrogel promoted the formation of pure hydroxyapatite (HAp) crystals, providing superior stiffness while maintaining ductility relative to GelMA-based hydrogels. In vitro, human bone marrow mesenchymal stem cells (hBMSCs) encapsulated in CMB hydrogels exhibited enhanced proliferation, cell–matrix interactions, and osteogenic differentiation, as evidenced by increased calcium deposition and histological analysis. These results demonstrate that the CMB hydrogel, enriched with extracellular matrix (ECM) components, shows considerable promise over current GelMA-based hydrogels for bone tissue engineering.